Trial intelligence / Profile preview

Reduction Of Microvascular Injury Utilizing Sonolysis

2014-002514-23Phase 2Active

Sponsor
Amsterdam University Medical Center
Start
Aug 2014
Modality
Drug Delivery Systems
Countries
1
01

Overview

Phase 2 trial of perflutren lipid microspheres in myocardial infarction (MI) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Echocardiographic infarct size and Enzymatic infarct size. Started Aug 2014; status: active.

02

Drugs

perflutren lipid microspheres
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2014-002514-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002514-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call